| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.3 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |